Pacira Pharmaceuticals and GeneAlign Announce Partnership to Develop Low-Opioid Pain Management Protocols for Postsurgical Patients at High Risk of Addiction
11/29/16 |
American College of Surgeons Launches Education Program on Opioids and Surgery: Use, Abuse, and Alternatives
11/22/16 |
Pacira Pharmaceuticals Unveils Virtual Reality Training Simulation to Enhance Administration Technique Education for EXPAREL® in Total Knee Replacement Surgery
11/11/16 |
Correction: Pacira Pharmaceuticals, Inc. to Present at Investor Conferences in November
11/10/16 |
Pacira Pharmaceuticals, Inc. to Present at Investor Conferences in November
11/10/16 |
Pacira Pharmaceuticals, Inc. Reports Third Quarter 2016 Financial Results
11/02/16 |
Pacira Pharmaceuticals Continues to Build Out Robust Commercial Leadership Team
10/20/16 |
Pacira Pharmaceuticals Announces Timing for Third Quarter 2016 Financial Results Webcast and Conference Call
10/17/16 |
Pacira Pharmaceuticals Announces Official Launch of EXPAREL to the Oral Surgeon Community to Treat Pain Following Oral and Maxillofacial Procedures
09/21/16 |
Pacira Pharmaceuticals, Inc. to Present at the Morgan Stanley Global Healthcare Conference
09/01/16 |
Pacira Pharmaceuticals, Inc. to Present at the 2016 Wedbush PacGrow Healthcare Conference
08/09/16 |
Pacira Pharmaceuticals, Inc. Reports Second Quarter 2016 Financial Results
08/04/16 |
New Research: Opioid Addiction and Dependence After Surgery is Significantly Higher than Previously Known
08/01/16 |
Pacira Pharmaceuticals Announces Timing for Second Quarter 2016 Financial Results Webcast and Conference Call
07/15/16 |
Pacira Pharmaceuticals, Inc. to Present at the Jefferies 2016 Healthcare Conference
05/31/16 |
Pacira Pharmaceuticals, Inc. to Present at the Bank of America Merrill Lynch 2016 Health Care Conference
05/03/16 |
Pacira Pharmaceuticals, Inc. Reports First Quarter 2016 Financial Results
05/02/16 |
Pacira Pharmaceuticals Appoints Charles A. Reinhart III as Chief Financial Officer
04/19/16 |
Pacira Pharmaceuticals Announces Timing for First Quarter 2016 Financial Results Webcast and Conference Call
04/14/16 |
Pacira Pharmaceuticals Appoints Robert Weiland as Chief Commercial Officer
04/05/16 |
Pacira Pharmaceuticals, Inc. to Present at the Barclays Global Healthcare Conference
03/08/16 |
New Analysis Shows Use of EXPAREL Reduces Length of Hospital Stay and Improves Discharge Status Compared to Standard Analgesic Modality in Total Knee Arthroplasty
03/01/16 |
Pacira Pharmaceuticals, Inc. Reports 2015 Financial Results
02/25/16 |
Pacira Pharmaceuticals Announces Timing for 2015 Financial Results Webcast and Conference Call
02/11/16 |
Pacira Pharmaceuticals Reports Estimated Full-Year 2015 Total Revenue of $249.0 Million
01/07/16 |
